Cidara Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CDTX and other ETFs, options, and stocks.

About CDTX

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak.

CEO

Jeffrey L. Stein

CEOJeffrey L. Stein

Employees

Employees73

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees73

CDTX Key Statistics

Market cap

1.06B

Market cap1.06B

Price-Earnings ratio

-26.83

Price-Earnings ratio-26.83

Dividend yield

—

Dividend yield—

Average volume

52.02K

Average volume52.02K

High today

$11.52

High today$11.52

Low today

$10.11

Low today$10.11

Open price

$10.18

Open price$10.18

Volume

41.66K

Volume41.66K

52 Week high

$29.60

52 Week high$29.60

52 Week low

$10.00

52 Week low$10.00

Cidara Therapeutics

Why Robinhood?

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. Show more

CDTX Key Statistics

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak.